Hamilton Lane Advisors LLC Kura Oncology, Inc. Transaction History

Hamilton Lane Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 31, 2020	SELL	$12.97 - $15.94 $505,155 - $620,831	-38,948 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$14.75 - $20.87 $422,779 - $598,196	28,663 Added 278.69%	38,948 $591,000
Q2 2019 Jul 29, 2019	SELL	$14.71 - $19.79 $7,913 - $10,647	-538 Reduced 4.97%	10,285 $203,000
Q1 2019 Apr 22, 2019	BUY	$13.73 - $16.87 $148,599 - $182,584	10,823 New	10,823 $180,000

181

80.2M

148K

63K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.31B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.